FDA Warning Letter — Doubletree Suites

Case 509738 — FEI 3010713486

The FDA took a Warning Letter action against Doubletree Suites on Nov 3, 2016 (Mount Laurel, NJ). The action was issued by CTP and concerns tobacco products.

Action details

Facility
Doubletree Suites
Date
Nov 3, 2016
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Mount Laurel, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.